Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming administration will offer support.

Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and adaptability

U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first that could curb smoking and hit tobacco industry earnings. The U.S. Food and Drug Administration (FDA),

A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far less addictive by reducing their nicotine content.

Discover why Altria may be a strong investment opportunity, with potential for significant total returns and a possible credit rating upgrade. Explore more here.

Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See why I upgrade my rating on MO to buy.

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes. The Food and Drug Administration OK'd 10 Zyn flavors,

Federal officials on Wednesday released a far-reaching proposal to make cigarettes far less addictive by capping their nicotine content, a goal long sought by antismoking advocates that

A proposed FDA rule would set nicotine levels on tobacco products at less than half the current average and could save millions of lives, proponents say.

The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.

In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price